Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.

Yendo TM, Sato MN, Branco ACCC, Pietrobon AJ, Teixeira FME, Ramos YÁL, Alberca RW, Valêncio CG, Arruda VN, Romiti R, Arnone M, Hirayama ALDS, Duarte AJDS, Aoki V, Orfali RL

Open source

DOI
10.3390/vaccines9050478
Published
2021 May 10
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines9050478,
  title = {Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.},
  author = {Yendo TM and Sato MN and Branco ACCC and Pietrobon AJ and Teixeira FME and Ramos YÁL and Alberca RW and Valêncio CG and Arruda VN and Romiti R and Arnone M and Hirayama ALDS and Duarte AJDS and Aoki V and Orfali RL},
  year = {2021},
  journal = {Vaccines},
  doi = {10.3390/vaccines9050478},
  url = {https://doi.org/10.3390/vaccines9050478}
}

RIS

TY  - JOUR
TI  - Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.
AU  - Yendo TM
AU  - Sato MN
AU  - Branco ACCC
AU  - Pietrobon AJ
AU  - Teixeira FME
AU  - Ramos YÁL
AU  - Alberca RW
AU  - Valêncio CG
AU  - Arruda VN
AU  - Romiti R
AU  - Arnone M
AU  - Hirayama ALDS
AU  - Duarte AJDS
AU  - Aoki V
AU  - Orfali RL
PY  - 2021
JO  - Vaccines
DO  - 10.3390/vaccines9050478
UR  - https://doi.org/10.3390/vaccines9050478
ER  - 

APA

TM, Y., MN, S., ACCC, B., AJ, P., FME, T., YÁL, R., RW, A., CG, V., VN, A., R, R., M, A., ALDS, H., AJDS, D., V, A., & RL, O. (2021). Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.. Vaccines. https://doi.org/10.3390/vaccines9050478

Source records